Clinical Trials Insight: 700028400
Phase of Trial: Phase I
Latest Information Update: 29 Apr 2008
At a glance
- Drugs NU 172 (Primary)
- Indications Thrombosis
- Focus Adverse reactions; Pharmacokinetics
- 29 Apr 2008 Status change from recruiting to completed, as reported in a Nuvelo media release.
- 29 Apr 2008 Interim results were reported in a Nuvelo media release.
- 31 Jan 2008 Status change from planning to recruiting.